Yes, thyroid problems can cause headaches, but the link is real in only a minority of cases. Both hypothyroidism and hyperthyroidism can produce head pain, most often a dull, bilateral, pressure-like headache rather than classic migraine. The mechanism runs through thyroid hormone effects on blood vessel tone, serotonin signaling, muscle tension, blood pressure, and sleep. Roughly 30 to 40 percent of people with untreated hypothyroidism report headaches, yet only about 1 to 3 percent of headache-clinic patients turn out to have a thyroid disorder. Treating the thyroid helps some, not all.
How Thyroid Hormone Changes Reach the Head
Thyroid hormone is not a headache drug or a headache toxin. It is a master regulator that sets the sensitivity of nearly every system that can generate head pain. When T3 and T4 fall or rise, four separate pathways shift at once, and any one of them can produce pain.
The first pathway is vascular. Thyroid hormone acts as a vasodilator in peripheral arteries. In hypothyroidism, peripheral vascular resistance rises and cerebral blood flow falls measurably in perfusion studies. That combination stiffens the arterial bed and slows flow, which is the opposite of the vasodilation that precedes migraine. The result is usually a steady, non-pulsating ache rather than a throbbing one.
The second pathway is serotonergic. T3 modulates serotonin receptor density and turnover in the brain. Low thyroid hormone is associated with reduced serotonergic transmission, and migraine is a disorder of serotonergic signaling. This shared chemistry is why some people with Hashimoto's thyroiditis report migraine attacks that track with their thyroid antibody titers, though the association is observational rather than proven.
The third pathway is muscular. Hypothyroidism causes a proximal myopathy that shows up as stiffness in the neck, shoulders, and jaw. Those are the same muscles that carry tension-type headache. A person with untreated hypothyroidism often has palpable trigger points in the upper trapezius before they ever notice fatigue or cold intolerance.
The fourth pathway is indirect and frequently missed: sleep. Hypothyroidism roughly doubles to triples the risk of obstructive sleep apnea through upper airway muscle changes and weight gain. Morning headache is a hallmark of sleep apnea, reported by roughly 15 to 30 percent of apnea patients. In this chain, the thyroid is the cause, apnea is the mechanism, and the headache is two steps removed.
Hyperthyroidism runs a different script. Excess thyroid hormone sensitizes beta-adrenergic receptors, raising heart rate, pulse pressure, and anxiety while fragmenting sleep. The resulting headache is more often pulsating and migraine-like, sometimes arriving with palpitations and heat intolerance. In plain terms: low thyroid tends to produce a pressure headache, and high thyroid tends to produce an agitated, throbbing one.
There is also a rare but documented fifth pathway. Hypothyroidism is a recognized secondary cause of elevated intracranial pressure, and small case series link it to a fraction of idiopathic intracranial hypertension cases. The headache there is worse lying down, worse with coughing, and often accompanied by visual changes. It is uncommon, but it is the reason a persistent daily headache in a hypothyroid patient deserves a fundoscopic exam.
How Often Do Thyroid Problems Cause Headaches?
The honest answer is that the effect is real but modest, and headline numbers get misread. Clinic-based series find recurrent headache in roughly 30 to 40 percent of overt hypothyroidism, 15 to 25 percent of overt hyperthyroidism, and 20 to 30 percent of subclinical hypothyroidism. Against a general adult baseline of about 20 to 25 percent with recurrent headache, that works out to roughly 1.4 to 1.6 times the background rate for overt hypothyroidism.
| Condition | Recurrent headache prevalence | Most common pattern | Typical lag from thyroid onset | Response to restoring normal hormone levels |
|---|---|---|---|---|
| Overt hypothyroidism (TSH above 10 mIU/L) | 30 to 40 percent | Bilateral, dull, pressure-like, tension-type | 4 to 12 weeks | Small series suggest roughly half improve within 12 weeks |
| Subclinical hypothyroidism (TSH 4.5 to 10 mIU/L) | 20 to 30 percent, close to background | Milder version of the above | Variable, often no clear lag | Weak and inconsistent |
| Graves disease or overt hyperthyroidism | 15 to 25 percent | Pulsating, migraine-like, with palpitations | 2 to 8 weeks | Usually eases once thyrotoxicosis is controlled |
| Levothyroxine over-replacement | 10 to 20 percent | Migraine-like or pressure | Days to weeks after a dose change | Resolves with dose reduction |
| General adult population | 20 to 25 percent | Mixed | Not applicable | Not applicable |
Read those rows together and the asymmetry becomes clear. About one in three people with untreated hypothyroidism reports recurrent headache, but only about one to three in 100 people who seek care at a headache clinic are found to have a new thyroid disorder. A thyroid cause is common among thyroid patients and rare among headache patients, and both statements are true at once.
That asymmetry has a practical consequence. It means thyroid testing is a high-yield move when a patient already has thyroid symptoms, and a low-yield move when the only complaint is headache. The pretest probability of finding something actionable in an unselected migraine population is roughly 1 to 2 percent, which is why headache guidelines do not recommend routine thyroid panels for migraine alone.
The absolute numbers also matter more than the relative risk. If the background rate of recurrent headache is 22 percent and hypothyroidism raises it to 35 percent, the absolute increase is 13 percentage points. That is a meaningful burden across a population, but it also means roughly two-thirds of hypothyroid patients will have headaches that are not explained by their thyroid at all.
The Timeline: When Thyroid Headaches Appear and Fade
Thyroid headache has a slow clock. Hormone levels shift over weeks, not minutes, so both the onset and the resolution unfold on a scale of months. The table below reflects typical timing for an adult started on weight-based levothyroxine, roughly 1.6 micrograms per kilogram per day.
| Time point | What happens | What to measure or do |
|---|---|---|
| Week 0 | Headache begins; other thyroid symptoms may be mild or absent | TSH, free T4, thyroid peroxidase antibodies |
| Weeks 1 to 2 | Levothyroxine started at full weight-based dose in healthy young adults | Start a dated headache diary |
| Weeks 2 to 4 | Headache can transiently worsen as hormone levels shift | Track sleep, blood pressure, and dose timing |
| Weeks 6 to 8 | First TSH recheck; dose adjusted in 12.5 to 25 microgram steps | TSH and free T4, drawn before the morning dose |
| Months 3 to 6 | Euthyroid state reached; headache often eases | Repeat TSH every 6 to 8 weeks until stable |
| Months 6 to 12 | Persistent headache at a normal TSH points elsewhere | Reassess diagnosis, screen for sleep apnea |
| Beyond 12 months | Stable maintenance dose | Annual TSH and symptom review |
Two features of this timeline surprise people. The first is that a brief worsening in weeks two to four is common and does not mean the treatment failed. The second is that six months of normal TSH with unchanged headache is strong evidence against a thyroid cause, not a reason to keep pushing the dose higher.
The lag also explains why headache is rarely the symptom that brings someone to a doctor. By the time a hypothyroid headache is established, fatigue, weight gain, cold intolerance, and constipation have usually been present for months. Headache is the symptom that gets remembered, not the one that arrives first.
Corrected Misconceptions and Non-Obvious Details
The single most common misconception is that a normal TSH rules out a thyroid contribution. It does not rule out fluctuation, over-replacement, or a shift in the reference range. A patient can be euthyroid on paper and still be under- or over-dosed for their own physiology, particularly in the first year of treatment when the set point is still being found.
A second misconception is that thyroid headaches are migraines. The dominant pattern in hypothyroidism is a bilateral, non-pulsating, pressure-type headache that meets criteria for tension-type headache, not migraine. The International Classification of Headache Disorders, third edition (2018), recognizes headache attributed to hypothyroidism as a distinct secondary headache, and its diagnostic criteria require a close temporal link plus improvement after euthyroidism is restored.
The non-obvious detail is that over-replacement is a more reliable headache trigger than under-replacement in treated patients. Levothyroxine has a narrow therapeutic index, and a dose that pushes TSH below 0.4 mIU/L produces palpitations, insomnia, and a migraine-like headache in 10 to 20 percent of patients. Clinicians who chase a low-normal TSH in a patient with persistent headache sometimes create the symptom they are trying to treat.
Another counterintuitive finding concerns thyroid antibodies. Hashimoto's thyroiditis with positive thyroid peroxidase antibodies has been associated with migraine in several observational cohorts, even when TSH is normal. The association is consistent enough to be interesting and too weak to be actionable. Antibody positivity marks immune activity, not hormone deficiency, and no trial has shown that treating antibody-positive euthyroid migraine patients reduces attack frequency.
A professional caveat worth stating plainly: temporal association is not causation. Headache is one of the most common symptoms in medicine, and thyroid disease is one of the most common chronic conditions, so the two will co-occur in large numbers of people by chance alone. The ICHD-3 criteria exist precisely to separate the cases where the link is plausible from the cases where it is coincidence.
Red Flags That Point Away From the Thyroid
Most thyroid-related headache is dull, gradual, and stable. The features below suggest a different diagnosis and warrant urgent evaluation regardless of thyroid status.
- A thunderclap headache that reaches maximum intensity within one minute.
- A first headache after age 50, especially with jaw claudication or scalp tenderness.
- Fever, neck stiffness, or a new rash alongside the headache.
- Focal weakness, numbness, speech change, or a new visual field defect.
- Headache that is clearly worse lying flat or with coughing and straining.
- A progressive pattern that worsens steadily over weeks rather than plateauing.
Papilledema on fundoscopy belongs on that list as well. It is the finding that turns a vague daily headache into an intracranial pressure workup, and hypothyroidism is one of the reversible causes worth excluding.
What to Actually Do
Start with the right test, not a panel. A serum TSH with a reflex free T4 answers the question in most cases, and adding thyroid peroxidase antibodies helps only when autoimmune disease is suspected. Total T3 and reverse T3 add cost and ambiguity without changing management in routine cases.
If hypothyroidism is confirmed, treat it properly before blaming or clearing it for headache. Levothyroxine should be taken on an empty stomach, 30 to 60 minutes before food, and separated from calcium, iron, and antacids by at least four hours. Those absorption rules change the effective dose by 20 to 40 percent, which is more than enough to move someone across a symptom threshold.
Set an explicit target and recheck on schedule. The laboratory reference range for TSH is 0.4 to 4.0 mIU/L, while many clinicians aim for 0.5 to 2.5 mIU/L in treated patients. These are not competing definitions of disease: the first describes the healthy population, the second describes a treatment goal, and both sit inside the same assay, so a treated patient at 3.0 mIU/L is normal by one standard and a candidate for a small dose adjustment by the other.
Keep a headache diary tied to the dose date. Record attack days, severity, sleep hours, and blood pressure. A headache that improves in the two weeks after a dose increase and returns before the next one is a strong signal that the dose is too low, and a headache that appears only in the first ten days after an increase suggests the step was too large.
Screen for the indirect causes rather than assuming the hormone is responsible. Ask about snoring, witnessed apneas, and morning grogginess, and use the STOP-BANG questionnaire when any of those are present. Check blood pressure at home over a week, because hypothyroidism raises diastolic pressure in a substantial minority and hypertension is itself a secondary headache cause.
Do not order thyroid tests for every headache, and do not repeat them more often than every six to eight weeks. Thyroid hormone has a half-life of about seven days, so a TSH drawn two weeks after a dose change is measuring noise. The American Thyroid Association's 2014 treatment guidelines recommend rechecking at six to eight weeks precisely because that is the interval at which the result becomes interpretable.
Limits of the Evidence
The literature on thyroid headache is built from small clinic series, cross-sectional surveys, and case reports. Headache definitions vary between studies, hypothyroidism is often self-reported rather than laboratory-confirmed, and few cohorts control for sleep apnea, blood pressure, or antidepressant use. That heterogeneity is why prevalence estimates span 15 to 40 percent rather than converging on a single figure.
Treatment response is the weakest link. There is no randomized trial of levothyroxine for headache, and the open-label series that exist cannot separate hormone effect from regression to the mean, since headaches naturally fluctuate over months. A patient who improves after starting treatment may simply have entered a quiet phase of their headache cycle.
The TSH reference range itself is contested. Some researchers argue the upper limit should be 2.5 mIU/L rather than 4.0 mIU/L, which would reclassify millions of people as hypothyroid overnight. That debate is unresolved, and it directly affects how many headaches get attributed to the thyroid.
Finally, causality cannot be established in an individual. A person with hypothyroidism and headache has two common conditions that may be linked, coincidental, or connected through a third factor such as sleep apnea or hypertension. The right clinical move is to treat the thyroid, watch the headache on a timeline, and let the response over three to six months answer the question the tests cannot.